The CDA gene helps your body break down cytidine, one of the chemical building blocks used to make DNA and RNA, and it also helps process some medicines. The protein made by this gene helps your cells keep these small molecules in balance. If the gene does not work well, some drugs, especially cytarabine and gemcitabine, may stay active longer and side effects can be stronger. Rare inherited variants can also upset the balance of DNA building blocks inside cells.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for making proteins, the working parts of cells. Others mainly control when certain processes take place, where they happen, and how strongly they run. Taken together, genes influence how the body develops and functions, and they can also shape how you respond to food, stress, or medications. To go into this topic in more detail, you can find more in the LearnHub.
Overview
CDAGene function
What if the gene works
Your cells rely on the CDA gene to break down cytidine and related molecules. This helps balance building blocks for DNA and RNA and supports how some medicines are processed.
Risk
What if the gene does not work
Milder to more severe variants in the CDA gene can reduce or disrupt the enzyme's activity. Cells then break down cytidine and deoxycytidine less effectively, which can change nucleoside balance and how some medicines are processed.
Treatment
What does that mean for your treatment
No CDA-specific treatment or management approach is currently established for people with a pathogenic variant in the CDA gene. The CDA gene is being studied as a biomarker for how some cancer drugs, especially cytarabine and gemcitabine, are broken down and whether side effects may be more likely, but this has not become standard care in clinical guidelines.
Gene function
What if the gene works
Your cells constantly make, use, and recycle small molecules that become part of DNA and RNA. The CDA gene helps manage part of that recycling system by changing certain building blocks into related forms. Understanding how the CDA gene works can make it easier to see how your cells keep these supplies in balance.
The CDA gene changes cytidine and deoxycytidine, two small molecules your cells use in DNA and RNA work, into related forms. This is part of normal chemical processing inside cells.
This gene supports a cell recycling route that lets the body reuse parts of genetic building blocks. That helps cells use materials efficiently as they make new RNA and prepare DNA.
By adjusting these small molecules, the CDA gene helps keep their levels balanced. A balanced supply supports steady cell growth and routine cell maintenance.
What is a variant?
Within a gene, a genetic variant is a small change in its DNA sequence. Variants are common and form part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many have no noticeable effect at all and simply reflect natural genetic variation. In some situations, however, a variant can more substantially affect gene function and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CDA gene can change how CDA gene variants affect enzyme activity by lowering how much enzyme a cell makes or by making the enzyme less stable and less able to work. Some changes have a mild effect and only partly reduce activity, while more disruptive variants can leave little or no working enzyme. Variants that alter the protein’s shape, interrupt it early, or affect RNA splicing (how the cell edits the gene message) usually have the largest functional impact.
How variants are linked to conditions
Current evidence on how variants of the CDA gene are linked to conditions is still evolving. The CDA gene does not yet have a broadly confirmed link to one specific inherited health condition, and reported findings have been limited or inconsistent across studies. If you have a confirmed result involving the CDA gene, your doctor or genetic counselor can explain what it means in the context of your own health.
A variant is not necessarily a diagnosis
Genetic variants are common and are a normal feature of human biology. Most do not directly affect health and simply reflect natural variation among people. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental factors are involved. Still, in some situations, one well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific everyday factors that increase or reduce health risk related to the CDA gene itself. In some settings, changes in CDA can affect how the body handles certain medicines, but personal risk still depends on the exact gene change and the health condition involved.
Inheritance of CDA variants
The way CDA gene variants are inherited is not tied to one broadly confirmed Mendelian condition at this time, so there is no single well-established pattern such as autosomal dominant or autosomal recessive that applies across the board. Research on how CDA gene variants are inherited continues to develop as scientists learn more about which changes have clear health effects. The CDA gene is located on chromosome 1, which is an autosome, so each person inherits one copy from each parent.
What does my CDA result mean for my family?
There isn't yet a broadly confirmed inheritance pattern tied to a specific health condition for CDA, though this understanding can change as research develops. If you have a specific CDA result and questions about what it could mean for your family, a doctor or genetic counselor can help explain it in the context of your relatives and your health history.
Genetic information
Genetic testing
How you find out about variants
To look for changes linked to the CDA gene, doctors use CDA genetic testing on a blood or saliva sample. A lab reads the DNA code in the CDA gene, sometimes as part of a larger gene panel, and the result may show a relevant variant, no relevant variant, or a variant whose health effect is still unclear.
When should I consider getting a genetic test?
There isn't yet a broadly established, CDA-specific clinical reason for genetic testing for most people. Decisions about testing are best made with a doctor or genetic counselor, based on your health history, family history, and sometimes plans for treatment with certain cancer medicines.
A genetic result is only one part of your health story
How much a genetic result can tell you varies with the condition and the type of variant involved, even though the result may still offer meaningful insight. Lifestyle, environment, age, and medical history are among the many factors that shape how the body works over time. With some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other aspects of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Two people can take the same treatment and have different results because their bodies may break down, transport, or respond to the drug in different ways. These inherited differences are common and can influence how well a medicine works or how sensitive someone is to side effects. Medication response is also shaped by other factors, including age, liver and kidney function, other medicines, and overall health.
What is Pharmacogenetics?
Pharmacogenetics examines the ways genetic differences affect how people respond to medications. By studying links between genes and drugs, it helps explain why the same treatment can work differently from one person to another. For many medicines, genes influence either how powerfully a drug works or how the body handles it. This information can support treatment choices that are more informed and more tailored to the individual. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the CDA gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in routine medication decisions, so general questions about side effects, treatment changes, or how a medicine may work for you are best discussed with your doctor. Some studies have looked at the CDA gene and how the body handles certain cancer medicines, especially gemcitabine and cytarabine, but this has not become standard guidance for everyday care.
History
CDA entered medical research through earlier studies of cytidine deaminase activity, which were part of the effort to map how cells handle nucleoside compounds. Initially understood only through visible traits, later recognized as tied to a specific gene, this work moved from biochemistry into human genetics. Building on this early work, scientists identified and mapped the CDA gene in the late 20th century. Interest then grew in cancer medicine as researchers linked inherited differences in CDA to variation in response to drugs such as cytarabine and gemcitabine. Over time, descriptions became more precise as genetic studies clarified which variants were most relevant in clinical research. This history made CDA better known in pharmacogenetics, the study of how genes can influence medicine response.